patent/UA-74324-C2

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abea201b56cda86db12933f769493f35
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536
filingDate	1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-74324-C2
titleOfInvention	FORMS OF CRYSTALLINE EFAVIREN AND METHODS OF TREATMENT WITH THEIR HELP
abstract	A potential reverse transcriptase inhibitor, efavirenz, exists in several physical forms, designated as forms 1, 2, 3, 4 and 5, and which differ in X-ray powder diffraction pattern and differential scanning calorimetry thermogram. Methods of treating HIV infection using these forms of efavirenz are also described.
priorityDate	1998-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139

Total number of triples: 17.